Reduction Mammoplasty: Clinical Trials

2 trials for Reduction Mammoplasty, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Reduction Mammoplasty: new trials by email Literature Review of Reduction Mammoplasty trials Research Report on Reduction Mammoplasty

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries
INL-001 (bupivacaine hydrochloride) implant - Pain, Postoperative, Hernia, Ventral
Phase 3CompletedInnocoll1002021-04-142023-02-13
Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.
Hematoma - Breast Reduction, Reduction Mammoplasty
CompletedMcMaster University802015-09-012017-09-12

Narrower conditions

Agnosia (1)  ·  Hematoma (1)  ·  Hemorrhage (1)  ·  Hernia (1)  ·  Hernia, Ventral (1)  ·  Pain (1)  ·  Pain, Postoperative (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Hernia, Abdominal (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Anatomical (1)  ·  Perceptual Disorders (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)

Interventions

Bupivacaine (1)  ·  Drug Implants (1)

Sponsors

Innocoll (1)  ·  McMaster University (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Achilleas Thoma, MD, MSc, BSc (1)  ·  Anne Arriaga (1)